MACQUARIE GROUP LTD - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$240,000
-53.8%
400,0000.0%0.00%
-100.0%
Q2 2023$520,000
-26.1%
400,0000.0%0.00%0.0%
Q1 2023$704,000
-43.9%
400,0000.0%0.00%0.0%
Q4 2022$1,256,000
-36.2%
400,000
-0.1%
0.00%
-50.0%
Q3 2022$1,970,000
+18.3%
400,260
-0.5%
0.00%0.0%
Q2 2022$1,665,000
-28.7%
402,1350.0%0.00%0.0%
Q1 2022$2,336,000
-22.5%
402,1350.0%0.00%
-33.3%
Q4 2021$3,016,000
-16.8%
402,1350.0%0.00%0.0%
Q3 2021$3,623,000
-24.7%
402,1350.0%0.00%
-25.0%
Q2 2021$4,814,000
-4.7%
402,135
-0.2%
0.00%
-42.9%
Q1 2021$5,051,000
-19.3%
403,111
+0.5%
0.01%
-22.2%
Q4 2020$6,262,000
+65.1%
401,2810.0%0.01%
+50.0%
Q3 2020$3,792,000
+4.6%
401,281
-0.8%
0.01%0.0%
Q2 2020$3,624,000
+42.2%
404,518
+1.1%
0.01%
+20.0%
Q1 2020$2,548,000
-23.9%
400,0000.0%0.01%0.0%
Q4 2019$3,348,000
-7.5%
400,0000.0%0.01%
-16.7%
Q3 2019$3,620,000
-72.0%
400,000
-66.7%
0.01%
-14.3%
Q2 2019$12,924,000
+1078.1%
1,200,000
+943.5%
0.01%
+250.0%
Q1 2019$1,097,000
+77.5%
115,000
+113.5%
0.00%
+100.0%
Q4 2018$618,000
-30.5%
53,852
+2.7%
0.00%0.0%
Q3 2018$889,000
+12.2%
52,452
-5.9%
0.00%0.0%
Q2 2018$792,000
+24.1%
55,762
+66.1%
0.00%0.0%
Q1 2018$638,000
+93.3%
33,566
+67.0%
0.00%0.0%
Q4 2017$330,000
+1122.2%
20,100
+1016.7%
0.00%
Q3 2017$27,0001,8000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders